Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like Repros Therapeutics Reports Fourth Quarter And Year End 2016 Financial Results March 30, 2017 Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense November 13, 2017 How High Novo Nordisk Could and Should Go for Ablynx January 23, 2018